10 Pharmaceutical Stocks to Buy Now According to Billionaire Kerr Neilson
In this article, we will look at 10 pharmaceutical stocks to buy now according to billionaire Kerr Neilson.
Epizyme Inc. (EPZM)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.50 | 22,666,667 | $34,000,000.50 | 31,833,334 | 2022-01-31 | Filing | |
| $7.80 | 217 | $1,692.60 | 150,900 | 2021-03-26 | Filing | |
| $7.97 | 34,269 | $273,123.93 | 150,683 | 2021-03-26 | Filing | |
| $7.98 | 28,231 | $225,283.38 | 116,414 | 2021-03-25 | Filing | |
| $12.07 | 5,000 | $60,350.00 | 5,000 | 2020-11-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.90 | 2,741 | $2,466.90 | 94,563 | 2022-04-11 | Filing | |
| $1.50 | 222 | $333.00 | 28,632 | 2022-02-07 | Filing | |
| $1.50 | 1,058 | $1,587.00 | 156,385 | 2022-02-07 | Filing | |
| $1.37 | 2,639 | $3,615.43 | 157,443 | 2022-02-02 | Filing | |
| $1.37 | 2,556 | $3,501.72 | 97,304 | 2022-02-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
15 Biotech and Pharmaceutical Stocks to Buy According to Palo Alto Investors
In this article, we will take a look at 15 biotech and pharmaceutical stocks to buy according to Palo Alto Investors.
5 Best Biotech Stocks to Buy According to Alan Frazier
In this article, we discuss the 5 best dividend stocks to buy according to Alan Frazier.
Here is What Hedge Funds Think About Epizyme Inc (EPZM)
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Is EPZM A Good Stock To Buy Now According To Hedge Funds?
In this article we will analyze whether Epizyme Inc (NASDAQ:EPZM) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas.
Top 5 Healthcare Stocks for the Future
Below we present the list of Top 5 Healthcare Stocks for the Future. For the first half of the list and an introduction to Dr.
Hedge Funds Are Getting Bullish On Epizyme Inc (EPZM)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Were Hedge Funds Right About Epizyme Inc (EPZM)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Hedge Fund and Insider Trading News: Waratah Capital Advisors, Dalton Investments, AQR Capital Management, CARN Capital, BrightSphere Investment Group Inc (BSIG), Dave & Buster's Entertainment Inc (PLAY), and More
Waratah Capital Advisors has launched the firm's second liquid alternative mutual fund, the Waratah Alternative ESG (AESG) Fund.
Hedge Funds Aren't Done Buying Epizyme Inc (EPZM)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.